Open Orphan - Contract for COVID-19 Vaccine Trial

Cathal Friel, Executive Chairman, Open Orphan announces a new contract with Codagenix to conduct a first in human (Phase I) trial evaluating safety and immunogenicity of a single-dose, intranasal COVID-19 vaccine candidate in 48 healthy young adult volunteers.

Cathal Friel
Executive Chairman

Company Events - OPEN ORPHAN

Open Orphan Presentation

Cathal Friel, CEO

Wed, 9 Oct 2019, 7:00am BST